Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 111

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 2
Chunk 111
---
 exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after our initial
business combination and (ii) with respect to the remaining 50% of the Private Placement Units, six months after the date of the consummation
of our initial business combination, or earlier, in either case, if, subsequent to our initial business combination, we consummate a
liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange
their ordinary shares for cash, securities or other property. The sponsor was granted certain demand and piggyback registration rights
in connection with the purchase of the Private Placement Units. No underwriting discounts or commissions were paid with respect to such
sale. The Private Placement Units were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
Act of 1933, as amended (the “Securities Act”).

Subsequently,
the underwriters exercised the over-allotment option in full, and the closing of the issuance and sale of the additional Units (the “Over-Allotment
Option Units”) occurred on February 18, 2025. The total aggregate issuance by us of 3,000,000 Over-Allotment Option Units at a
price of $10.00 per unit resulted in total gross proceeds of $30,000,000. On February 18, 2025, simultaneously with the sale of the Over-Allotment
Option Units, we consummated the private sale of an additional 30,000 Private Placement Units, generating gross proceeds of $300,000.

Following
the closing of the IPO, a total of $ 231,150,000 of the net proceeds from the sale of Units in the IPO (including the Over-Allotment
Option Units) and the private placement of the Private Placement Units, were placed in a trust account established for the benefit of
the Company’s public shareholders (the “trust account”) established by VStock Transfer, LLC, our transfer agent and
maintained by Wilmington Trust, National Association acting as trustee. Except with respect to interest earned on the funds held in the
trust account that may be released to us to pay our taxes, if any, the funds held in the trust account will not be released from the
trust account until